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Central line–associated bloodstream infections (CLABSIs) remain a threat to hospitalized 
patients.1 Patients with burn injuries are especially vulnerable to CLABSI, because the burn 
wound area can become colonized with pathogens, and prolonged hospital stays are 
common. In addition, large surface burns have a systemic immunomodulatory effect, such as 
skewing the immune system toward an interleukin 17–mediated response.2 In this study, we 
evaluated CLABSI incidence trends in a large burn intensive care unit (ICU).
This study was conducted at the University of North Carolina (UNC) Hospitals using 
surveillance data from 1999 to 2012. UNC Hospitals is an 806-bed tertiary care academic 
facility. All patients admitted to the Jaycee Burn Center ICU, which is a 21-bed ICU 
dedicated to the care of severely ill patients with burns or extensive exfoliating skin 
conditions, were included. The number of ICU beds was 10 during the period 1999–2007 
and increased to its current number of 21 beds in 2008. From 200 to 2009, a number of 
interventions directed toward decreasing the CLABSI rate were implemented (Table 1).
Infection control at UNC Hospitals is provided by 5 infection preventionists and 3 faculty 
members. Comprehensive hospital-wide surveillance was conducted using the most recent 
definitions recommended by the National Nosocomial Infection Surveillance3 and the 
National Healthcare Safety Network.4 Rates of CLABSI were calculated as the number of 
infections per 1,000 central line–days. Simple linear regression models (least-squares 
method) were used to examine decreases in the rate of CLABSI over time. Statistical 
significance was assessed by comparing these regression lines with a line with a 0 slope.
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The annual number of central line–days in the burn ICU increased from 1,493 days in 1999 
to 3,223 days in 2012. At the same time the absolute number of CLABSI decreased from 21 
CLABSI in 1999 to 7 CLABSI in 2012. This resulted in a substantial decrease in the rate of 
CLABSI in the burn ICU from 14.07 to 2.17 CLABSI per 1,000 central line–days (Figure 
1). Over the period 2000–2012, we prevented an estimated 428 infections at a total cost 
savings of $9,947,576, based on published cost data and 118 deaths.5 When evaluating the 
other ICUs during the study period, a reduction in the rate of CLABSI was also noted. Of 
note, since 2004, the rates of CLABSI in the burn ICU have been very similar to those in 
other ICUs. When the specific microbiologic etiologies were evaluated, a decrease in the 
number of CLABSI caused by Staphylococcus aureus was noted (Figure 1).
A sustained decreased CLABSI rate was observed in the burn ICU. Most interventions were 
implemented hospital-wide, and their effect was observed not only in the burn ICU, but in 
all ICUs, as previously reported.6 Some interventions were unique to the burn population. 
The frequency of line changes remains controversial in this population. The 2008 Society for 
Healthcare Epidemiology of America (SHEA)/ Infectious Diseases Society of America 
(IDSA) guidelines do not recommend routine line changes.7 A small study using historical 
controls was performed among burn patients to compare line changes every 3 days with line 
changes every 4 days.8 This study suggested that increasing the interval was associated with 
an increase in episodes of CLABSI.8 A survey of CLABSI-prevention practices across 51 
adult burn units in the United States certified by the American Burn Association showed that 
61% of burn units practice routine prophylactic line changes with an interval ranging from 3 
to 7 days.9 In our cohort, line change practice included a guidewire exchange every 3 days 
and changing to a new site every 6 days.
Antibiotic-impregnated central venous catheters were used in our cohort as well as in 43% 
of burn units surveyed.9 The use of antibiotic-impregnated catheters is recommended in the 
2008 SHEA/IDSA guidelines in hospital units with a CLABSI rate higher than the 
institutional goal, despite compliance with basic CLABSI-prevention practices.7
In 2006, universal glove and gown use was implemented in our burn ICU. This measure was 
not implemented in any other type of ICU in our hospital. The relative impact of this 
intervention on our CLABSI rate was likely modest, because most of the reduction in 
CLABSI rates occurred before this intervention. A recent cluster-randomized trial evaluated 
the impact of universal glove and gown use in non-burn ICUs.10 Their findings included a 
reduction in the acquisition of MRSA, but not of VRE. No changes in CLABSI rates were 
observed.10 We noted that most of the reduction was driven by a dramatic reduction in gram-
positive organisms, mirroring the national trends.1
In summary, we observed a large, sustained, and prolonged reduction in the rate of CLABSI 
in the burn ICU. This reduction was temporally associated with the implementation of a 
multifaceted proactive approach to CLABSI prevention.
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Trends in overall central line–associated bloodstream infection (CLABSI) rate and number 
of Staphylococcus aureus CLABSIs in the burn intensive care unit (BICU). The solid black 
line indicates the rate of CLABSI in the BICU, and the dashed line indicates the rate of 
CLABSI in all other intensive care units (ICUs). The gray line is the regression line of the 
rate of CLABSI in the BICU (P = .0005). Shaded bars show the number of CLABSIs in the 
BICU per year caused by S. aureus.
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TABLE 1
Interventions to Reduce Central Line–Associated Bloodstream Infections (CLABSIs) at University of North 
Carolina Hospitals, 2000–2009
Year(s) Intervention(s)
2000 Enhanced education of medical staff regarding central lines; addition of 2% chlorhexidine plus 70% isopropyl alcohol for skin 
preparation to central line kits
2001 Mandatory training for nurses on IV line site care and maintenance
2003 Central line changes over a guidewire every 3 days with use of a new site every 6 days becomes standard practice;a use of full 
body drape for line insertion and changes
2003–2005 Introduction of antibiotic-impregnated central venous catheters for all patients
2004 Enhanced nursing education on central line insertion and maintenance
2005 Customized catheter-insertion kits
2006 Universal glove and gown use for all patient encountersa
2007 Implementation of the Institute for Healthcare Improvement bundle to prevent CLABSI
2009 Use of chlorhexidine patch at insertion site
NOTE. IV, intravenous.
a
Specific to the burn ICU.
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